KRAS and malignant colon neoplasm: The colon cancer cohort consisted of 151 samples, 96 (64%) of which harbored pathogenic mutations in their ctDNA, with the most commonly mutated genes being TP53 (50%), KRAS (32%), PIK3CA (7%), and BRAF (5%) (Figure 4, Table 3).